CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Context Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$0.24−0.01 (-2.30%)
Close on Oct 19, 2026
- Market cap
- $22.69M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Context Therapeutics from other investors
No posts about CNTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.